Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Fax: 908 375 8272

Website: www.cormedix.com

Address:

300 Connell Drive, Suite 4200, Berkeley Heights, United States

TSLA_S3XY Jun. 18 at 12:36 AM

$CRMD Typical Date Range for “Mid-2025” • Start of Range: June 1, 2025 • Midpoint (Exact Middle of Year): July 2, 2025 (Wednesday) • End of Range: July 31, 2025

0 · Reply

JackNapier22 Jun. 18 at 12:00 AM

$CRMD either a correction is coming or they had a great effort in shaking out the shakeable - we shall see

1 · Reply

winston319 Jun. 17 at 10:33 PM

$CRMD so here we are still in limbo.

0 · Reply

Noname2022 Jun. 17 at 10:32 PM

$CRMD While we wait for Joe to verify LDO1 orders; Here’s a cool video about how to use Defencath. Fun Fact: defencath can be used during HD at home (like emphasized as an emerging area during FMC investor call today) https://www.youtube.com/watch?v=iDQQULHHMfA

1 · Reply

Oct Jun. 17 at 10:26 PM

$CRMD Smiling quietly... has anyone here ever heard the old adage., "Nothing is ever as good as it seems AND nothing is ever as bad as it seems"! Truth!!!

1 · Reply

BioLove Jun. 17 at 9:37 PM

$CRMD if the market bounces, this will most likely follow suit.

2 · Reply

InverseBart Jun. 17 at 9:03 PM

$CRMD It seems this is heading to retest. Let's see how deep it retraces.

1 · Reply

Shibby_Boss Jun. 17 at 8:19 PM

$CRMD Could retrace to high 12s low 13s as RSI resets

0 · Reply

JackNapier22 Jun. 17 at 5:45 PM

$CRMD someone is buying the $16’s today hard to believe realistic last day for news would be tomorrow 🤷‍♂️

2 · Reply

SweStonk Jun. 17 at 5:34 PM

$CRMD did I hit the top? 🤑 where is the floor? 😏 We will see the coming weeks

1 · Reply

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 13 days ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 18 days ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 4 weeks ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 6 weeks ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 6 weeks ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 7 weeks ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 7:30 AM EDT - 2 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 3:01 AM EDT - 2 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 25, 2025, 10:51 AM EDT - 3 months ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 7:30 AM EDT - 3 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 9:21 AM EDT - 3 months ago

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 18, 2025, 8:30 AM EDT - 3 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

Jan 7, 2025, 7:30 AM EST - 5 months ago

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Dec 19, 2024, 8:30 AM EST - 6 months ago

CorMedix Inc. Added to Nasdaq Biotechnology Index

Nov 26, 2024, 8:30 AM EST - 7 months ago

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Nov 8, 2024, 8:00 AM EST - 7 months ago

Stock Picks From Seeking Alpha's October 2024 New Analysts

ACGL AMCX AMPS APOG AVRE BHP BILL

Nov 4, 2024, 8:30 AM EST - 8 months ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

Oct 30, 2024, 12:32 PM EDT - 8 months ago

CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:30 AM EDT - 8 months ago

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

Oct 28, 2024, 1:33 PM EDT - 8 months ago

CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 25, 2024, 2:30 PM EDT - 8 months ago

Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital +

Oct 24, 2024, 8:30 AM EDT - 8 months ago

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

Oct 23, 2024, 8:30 AM EDT - 8 months ago

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

Sep 13, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

Sep 9, 2024, 10:52 AM EDT - 10 months ago

CorMedix Inc. Announces New Commercial Agreement

Aug 14, 2024, 2:08 PM EDT - 10 months ago

CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 10 months ago

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

Aug 7, 2024, 8:30 AM EDT - 11 months ago

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

Jul 3, 2024, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Outpatient Availability of DefenCath

Jun 6, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

May 28, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

May 11, 2024, 5:48 PM EDT - 1 year ago

CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript

May 10, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

May 9, 2024, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

May 6, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024

Apr 19, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Apr 15, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)

Apr 11, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference

Apr 8, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC

Mar 12, 2024, 11:17 AM EDT - 1 year ago

CorMedix (CRMD) Q4 2023 Earnings Call Transcript

TSLA_S3XY Jun. 18 at 12:36 AM

$CRMD Typical Date Range for “Mid-2025” • Start of Range: June 1, 2025 • Midpoint (Exact Middle of Year): July 2, 2025 (Wednesday) • End of Range: July 31, 2025

0 · Reply

JackNapier22 Jun. 18 at 12:00 AM

$CRMD either a correction is coming or they had a great effort in shaking out the shakeable - we shall see

1 · Reply

winston319 Jun. 17 at 10:33 PM

$CRMD so here we are still in limbo.

0 · Reply

Noname2022 Jun. 17 at 10:32 PM

1 · Reply

Oct Jun. 17 at 10:26 PM

$CRMD Smiling quietly... has anyone here ever heard the old adage., "Nothing is ever as good as it seems AND nothing is ever as bad as it seems"! Truth!!!

1 · Reply

BioLove Jun. 17 at 9:37 PM

$CRMD if the market bounces, this will most likely follow suit.

2 · Reply

InverseBart Jun. 17 at 9:03 PM

$CRMD It seems this is heading to retest. Let's see how deep it retraces.

1 · Reply

Shibby_Boss Jun. 17 at 8:19 PM

$CRMD Could retrace to high 12s low 13s as RSI resets

0 · Reply

JackNapier22 Jun. 17 at 5:45 PM

$CRMD someone is buying the $16’s today hard to believe realistic last day for news would be tomorrow 🤷‍♂️

2 · Reply

SweStonk Jun. 17 at 5:34 PM

$CRMD did I hit the top? 🤑 where is the floor? 😏 We will see the coming weeks

1 · Reply

InvestorM Jun. 17 at 5:22 PM

$CRMD Same old story. Goes up on news. Then prolonged silence, goes down. Then wait till next PR for recovery. Corrupt LDOs care the least about infection prevention.

0 · Reply

BeeeeDooooh Jun. 17 at 5:21 PM

$CRMD no volume today

1 · Reply

wolverine Jun. 17 at 5:07 PM

$CRMD did someone just buy 200 $23 options expiring in 3 days?

1 · Reply

VictoryFormation Jun. 17 at 4:56 PM

$CRMD Feels like we're gonna get F'ed again because F is going to F us over with open-ended delays. They made excuses awhile back about phosphate binders that were recently added to the bundle being the cause of the delay. Wonder what it's gonna be now?

1 · Reply

ROfish Jun. 17 at 4:53 PM

$CRMD you are going the wrong way. I still love you though.

1 · Reply

Newageinvestor Jun. 17 at 4:00 PM

$CRMD This is gaining attention on another Bio Board that I follow, so looked up the information on FDA.Gov. https://www.fda.gov/news-events/press-announcements/fda-issue-new-commissioners-national-priority-vouchers-companies-supporting-us-national-interests Very interesting and could be a huge money saver for the right Biotech company with the right indication. Maybe TPN could fall into this category.

1 · Reply

mrices Jun. 17 at 3:54 PM

The biggest margin improvement opportunity for F is to put patients on Defencath, where F would earn $65+ for each patient visit. Looking at slides 20-21 there is no mention of Defencath or reference to potential profit improvement. Given the delays in starting even pilot program I am thinking this may not happen in Q3 or Q4.$CRMD

4 · Reply

Shibby_Boss Jun. 17 at 3:45 PM

$CRMD sold 1/2 at 14.60. Waiting for RSI to cool off. Main risk is unexpected buyout / unexpected LMO news

0 · Reply

tballgame Jun. 17 at 3:16 PM

$CRMD added. Will add weekly. Better than sitting on cash. We are an LDO announcement and one ER away from big moves up imo

0 · Reply

ThinkVest Jun. 17 at 2:33 PM

$CRMD

1 · Reply

4ezmony Jun. 17 at 2:11 PM

$CRMD LDO... LDO... LDO... Let's go! 🤑

0 · Reply

Derfzilla Jun. 17 at 1:40 PM

$CRMD

0 · Reply

Market Cap	972.61M
Revenue (ttm)	43.47M
Net Income (ttm)	-17.93M
EPS (ttm)	N/A
PE Ratio	66.18
Forward PE	15.66
Profit Margin	-41.25%
Debt to Equity Ratio	0.00

Volume	1,134,800
Avg Vol	1,801,924
Day's Range	N/A - N/A
Shares Out	67.83M
Stochastic %K	55%
Beta	1.62
Analysts	Strong Sell
Price Target	$16.83